FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2951818194> ?p ?o ?g. }

• W2951818194 abstract "Background: SLE may be stratified according to a range of different immune assessments but the relationships between these are less well defined. MASTERPLANS is an MRC-funded consortium that seeks to identify immunophenotypic subgroups of patients that predict response to therapy. Objectives: Our objective here was to analyse a clinically well-phenotyped patients using a suite of immune assessments and identify inter-relationships between these features as well as subgroups of patients who may differ in response to therapy. Methods: 143 SLE patients were evaluated for clinical phenotype using BILAG-2004, autoantibodies using radioimmunoprecipitation (IP, University of Bath), two interferon scores (IFN-Score-A and IFN-Score-B), flow cytometry for major circulating immune cell subsets, as well as the surface protein expression of tetherin on each subset, a cell-specific assay for IFN response. Unsupervised hierarchical clustering was used to define autoantibody subgroups. IFN scores (reflected dCT) were compared between the groups using multivariate models. Other variables were compared using Kruskal-Wallis test with pairwise comparisons. Results: Using IP, 141 patients could be divided into five subgroups: U1RNP/Sm+ only (n=23), Ro60+ only (n=8), U1RNP/Sm+Ro60+ (n=6), Ro60+Ro52+La+ (n=11), Ro52+ (n=16) and other ANA (n=77). Antibody subgroups was strongly associated with IFN-Score-A (F=4.39, p=0.001). Expression was lowest for “other ANA”, intermediate for single antibody groups, and highest with multiple positive antibodies. Multivariate linear regression, including interaction terms between antibody types, revealed that Ro60 and U1RNP/Sm were the independent predictors of IFN-Score-A level (p=0.051 and 0.009 respectively). There was no association between autoantibody status and IFN-Score-B (F=0.973, p=0.438). In flow cytometry, the U1RNP/Sm group was notable for significantly lower numbers of CD4-T-cells and memory-B-cells. Memory -B-cells were also lower in antibody-positive groups compared to “other ANA”. Tetherin expression was increased in antibody positive groups, but to a similar extent on most cell subsets. Memory B cell tetherin was significantly higher in the groups with multiple positive antibodies. U1RNP/Sm+ was associated with renal involvement (p=0.004). Mucocutaneous involvement was greater in the Ro60+Ro52+La+ group (p=0.037). Conclusion: This cohort revealed relationships between immune features. U1RNP/Sm antibody was notable for defining a group of patients with a cluster of immune abnormalities, including the greatest elevation of IFN activity, greater abnormalities on flow cytometry and clinical renal involvement. This was independent to the IFN-Score-B high status that predicts better clinical response to rituximab (presented elsewhere at this conference). Future work in MASTERPLANS will investigate the significance of these subgroups for response to therapy. Disclosure of Interests: Marta Aguilar-Zamora: None declared, Hui Lu: None declared, Zoe Betteridge: None declared, Katie Dutton: None declared, Md Yuzaiful Md Yusof: None declared, Antonios Psarras: None declared, The MASTERPLANS Consortium. : None declared, Neil McHugh: None declared, Edward Vital Grant/research support from: He has received honoraria and research grant support from Roche, GSK and AstraZeneca." @default.
• W2951818194 created "2019-06-27" @default.
• W2951818194 creator A5023290270 @default.
• W2951818194 creator A5024716499 @default.
• W2951818194 creator A5027379087 @default.
• W2951818194 creator A5039052006 @default.
• W2951818194 creator A5043900874 @default.
• W2951818194 creator A5068637534 @default.
• W2951818194 creator A5071947542 @default.
• W2951818194 creator A5077233961 @default.
• W2951818194 date "2019-06-01" @default.
• W2951818194 modified "2023-09-27" @default.
• W2951818194 title "FRI0218 IMMUNOPHENOTYPIC SUBGROUPS OF SLE DEFINED BY AUTOANTIBODIES, GENE EXPRESSION AND FLOW CYTOMETRIC ANALYSIS" @default.
• W2951818194 doi "https://doi.org/10.1136/annrheumdis-2019-eular.5872" @default.
• W2951818194 hasPublicationYear "2019" @default.
• W2951818194 type Work @default.
• W2951818194 sameAs 2951818194 @default.
• W2951818194 citedByCount "0" @default.
• W2951818194 crossrefType "proceedings-article" @default.
• W2951818194 hasAuthorship W2951818194A5023290270 @default.
• W2951818194 hasAuthorship W2951818194A5024716499 @default.
• W2951818194 hasAuthorship W2951818194A5027379087 @default.
• W2951818194 hasAuthorship W2951818194A5039052006 @default.
• W2951818194 hasAuthorship W2951818194A5043900874 @default.
• W2951818194 hasAuthorship W2951818194A5068637534 @default.
• W2951818194 hasAuthorship W2951818194A5071947542 @default.
• W2951818194 hasAuthorship W2951818194A5077233961 @default.
• W2951818194 hasBestOaLocation W29518181941 @default.
• W2951818194 hasConcept C126322002 @default.
• W2951818194 hasConcept C159654299 @default.
• W2951818194 hasConcept C163764329 @default.
• W2951818194 hasConcept C203014093 @default.
• W2951818194 hasConcept C38180746 @default.
• W2951818194 hasConcept C553184892 @default.
• W2951818194 hasConcept C71924100 @default.
• W2951818194 hasConcept C8891405 @default.
• W2951818194 hasConceptScore W2951818194C126322002 @default.
• W2951818194 hasConceptScore W2951818194C159654299 @default.
• W2951818194 hasConceptScore W2951818194C163764329 @default.
• W2951818194 hasConceptScore W2951818194C203014093 @default.
• W2951818194 hasConceptScore W2951818194C38180746 @default.
• W2951818194 hasConceptScore W2951818194C553184892 @default.
• W2951818194 hasConceptScore W2951818194C71924100 @default.
• W2951818194 hasConceptScore W2951818194C8891405 @default.
• W2951818194 hasLocation W29518181941 @default.
• W2951818194 hasOpenAccess W2951818194 @default.
• W2951818194 hasPrimaryLocation W29518181941 @default.
• W2951818194 hasRelatedWork W2318054521 @default.
• W2951818194 hasRelatedWork W2320451797 @default.
• W2951818194 hasRelatedWork W2327126102 @default.
• W2951818194 hasRelatedWork W2328030129 @default.
• W2951818194 hasRelatedWork W2334067888 @default.
• W2951818194 hasRelatedWork W2594889731 @default.
• W2951818194 hasRelatedWork W2609073214 @default.
• W2951818194 hasRelatedWork W2755440377 @default.
• W2951818194 hasRelatedWork W2917728585 @default.
• W2951818194 hasRelatedWork W2949416627 @default.
• W2951818194 hasRelatedWork W2950134454 @default.
• W2951818194 hasRelatedWork W2951555556 @default.
• W2951818194 hasRelatedWork W3034126123 @default.
• W2951818194 hasRelatedWork W3034762969 @default.
• W2951818194 hasRelatedWork W3034845912 @default.
• W2951818194 hasRelatedWork W3035528489 @default.
• W2951818194 hasRelatedWork W3036466175 @default.
• W2951818194 hasRelatedWork W3042687423 @default.
• W2951818194 hasRelatedWork W3093579187 @default.
• W2951818194 hasRelatedWork W3096149685 @default.
• W2951818194 isParatext "false" @default.
• W2951818194 isRetracted "false" @default.
• W2951818194 magId "2951818194" @default.
• W2951818194 workType "article" @default.